Velibor Krstic Exits Position in Strata Critical Medical, Inc. Following Warrant Expiration

Velibor Krstic, a private investor based in Switzerland, has filed Amendment No. 3 to his Schedule 13D, reporting a complete exit from his position in Strata Critical Medical, Inc. (SRTA). The filing indicates that 1,577,500 warrants to purchase Class A Common Stock (SRTAW) expired worthless on May 7, 2026. These warrants were originally issued under a Warrant Agreement dated September 12, 2019. Prior to the expiration, Krstic held a significant 16.2% stake in the class. As a result of the warrants reaching their expiration date without being exercised, Krstic's beneficial ownership has been reduced to zero shares and 0.0% of the class. This filing serves as the final amendment to his Schedule 13D, as he no longer holds more than five percent of the subject securities. No funds were received in connection with the expiration, and the investor confirmed that no other contracts or arrangements exist regarding the issuer's securities.